These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 32843547)

  • 1. Kaposi's Sarcoma-Associated Herpesvirus Drives a Super-Enhancer-Mediated Survival Gene Expression Program in Primary Effusion Lymphoma.
    Manzano M; Günther T; Ju H; Nicholas J; Bartom ET; Grundhoff A; Gottwein E
    mBio; 2020 Aug; 11(4):. PubMed ID: 32843547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global epigenomic analysis of KSHV-infected primary effusion lymphoma identifies functional
    Park A; Oh S; Jung KL; Choi UY; Lee HR; Rosenfeld MG; Jung JU
    Proc Natl Acad Sci U S A; 2020 Sep; 117(35):21618-21627. PubMed ID: 32817485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclooxygenase-2-prostaglandin E2-eicosanoid receptor inflammatory axis: a key player in Kaposi's sarcoma-associated herpes virus associated malignancies.
    Paul AG; Chandran B; Sharma-Walia N
    Transl Res; 2013 Aug; 162(2):77-92. PubMed ID: 23567332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Druggable host gene dependencies in primary effusion lymphoma.
    Kuehnle N; Gottwein E
    Curr Opin Virol; 2022 Oct; 56():101270. PubMed ID: 36182745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CADM1 is essential for KSHV-encoded vGPCR-and vFLIP-mediated chronic NF-κB activation.
    Hunte R; Alonso P; Thomas R; Bazile CA; Ramos JC; van der Weyden L; Dominguez-Bendala J; Khan WN; Shembade N
    PLoS Pathog; 2018 Apr; 14(4):e1006968. PubMed ID: 29698475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Kaposi's Sarcoma-associated Herpesvirus-encoded vIRF-3 Inhibits Cellular IRF-5.
    Wies E; Hahn AS; Schmidt K; Viebahn C; Rohland N; Lux A; Schellhorn T; Holzer A; Jung JU; Neipel F
    J Biol Chem; 2009 Mar; 284(13):8525-38. PubMed ID: 19129183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR/Cas9 ablating viral microRNA promotes lytic reactivation of Kaposi's sarcoma-associated herpesvirus.
    Liang Z; Qin Z; Riker AI; Xi Y
    Biochem Biophys Res Commun; 2020 Dec; 533(4):1400-1405. PubMed ID: 33092788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting Myc in KSHV-associated primary effusion lymphoma with BET bromodomain inhibitors.
    Tolani B; Gopalakrishnan R; Punj V; Matta H; Chaudhary PM
    Oncogene; 2014 May; 33(22):2928-37. PubMed ID: 23792448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kaposi's sarcoma-associated herpesvirus at 27.
    Gaglia MM
    Tumour Virus Res; 2021 Dec; 12():200223. PubMed ID: 34153523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-1 Receptor-Associated Kinase (IRAK) Signaling in Kaposi Sarcoma-Associated Herpesvirus-Induced Primary Effusion Lymphoma.
    Seltzer J; Moorad R; Schifano JM; Landis JT; Dittmer DP
    J Virol; 2020 May; 94(10):. PubMed ID: 32161170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of interferon regulatory factor 7 (IRF7)-mediated interferon signal transduction by the Kaposi's sarcoma-associated herpesvirus viral IRF homolog vIRF3.
    Joo CH; Shin YC; Gack M; Wu L; Levy D; Jung JU
    J Virol; 2007 Aug; 81(15):8282-92. PubMed ID: 17522209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of KSHV-infected primary effusion lymphomas in NOD/SCID mice by gamma-secretase inhibitor.
    Lan K; Murakami M; Bajaj B; Kaul R; He Z; Gan R; Feldman M; Robertson ES
    Cancer Biol Ther; 2009 Nov; 8(22):2136-43. PubMed ID: 19783901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated IL-13 in effusions of patients with HIV and primary effusion lymphoma as compared with other Kaposi sarcoma herpesvirus-associated disorders.
    Ramaswami R; Lurain K; Marshall VA; Rupert A; Labo N; Cornejo-Castro E; Miley W; Wang HW; Widell A; Lindsley M; Yuan C; Stetler-Stevenson M; Filie AC; Whitby D; Ziegelbauer JM; Uldrick TS; Yarchoan R
    AIDS; 2021 Jan; 35(1):53-62. PubMed ID: 33273183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancer-promoter activation by the Kaposi sarcoma-associated herpesvirus episome maintenance protein LANA.
    Ye X; Guerin LN; Chen Z; Rajendren S; Dunker W; Zhao Y; Zhang R; Hodges E; Karijolich J
    Cell Rep; 2024 Mar; 43(3):113888. PubMed ID: 38416644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viral, immunologic, and clinical features of primary effusion lymphoma.
    Lurain K; Polizzotto MN; Aleman K; Bhutani M; Wyvill KM; Gonçalves PH; Ramaswami R; Marshall VA; Miley W; Steinberg SM; Little RF; Wilson W; Filie AC; Pittaluga S; Jaffe ES; Whitby D; Yarchoan R; Uldrick TS
    Blood; 2019 Apr; 133(16):1753-1761. PubMed ID: 30782610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversible switching of primary cells between normal and malignant state by oncogenic virus KSHV and CRISPR/Cas9-mediated targeting of a major viral latent protein.
    Ju E; Li T; Ramos da Silva S; Markazi A; Gao SJ
    J Med Virol; 2021 Aug; 93(8):5065-5075. PubMed ID: 33942339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PAX5 functions as a tumor suppressor by RB-E2F-mediated cell cycle arrest in Kaposi sarcoma-associated herpesvirus-infected primary effusion lymphoma.
    Goto H; Kariya R; Kudo E; Katano H; Okada S
    Neoplasia; 2024 Oct; 56():101035. PubMed ID: 39096792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The chromatin modification by SUMO-2/3 but not SUMO-1 prevents the epigenetic activation of key immune-related genes during Kaposi's sarcoma associated herpesvirus reactivation.
    Chang PC; Cheng CY; Campbell M; Yang YC; Hsu HW; Chang TY; Chu CH; Lee YW; Hung CL; Lai SM; Tepper CG; Hsieh WP; Wang HW; Tang CY; Wang WC; Kung HJ
    BMC Genomics; 2013 Nov; 14(1):824. PubMed ID: 24267727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kaposi's sarcoma-associated herpesvirus microRNA single-nucleotide polymorphisms identified in clinical samples can affect microRNA processing, level of expression, and silencing activity.
    Han SJ; Marshall V; Barsov E; Quiñones O; Ray A; Labo N; Trivett M; Ott D; Renne R; Whitby D
    J Virol; 2013 Nov; 87(22):12237-48. PubMed ID: 24006441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of constitutive signaling of Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor by protein kinases in mammalian cells in culture.
    Geras-Raaka E; Arvanitakis L; Bais C; Cesarman E; Mesri EA; Gershengorn MC
    J Exp Med; 1998 Mar; 187(5):801-6. PubMed ID: 9480990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.